Is The Pause In The Oxford Vaccine Trial A Setback? | BOOM

In case of the Astrazeneca trial, we need to wait for more evidence to know if the neurological side effect in the patient is related to the vaccine or other conditions before we move forward with the trials. This will also cause serious concern among trial participants from being included in future trials so we need transparency in process just like regulators have rightly done with Oxford vaccine trials.